Sarepta Therapeutics (SRPT) Other Non Operating Income (2010 - 2026)

Sarepta Therapeutics' Other Non Operating Income history runs 17 years deep, the most recent figure standing at -$15.3 million for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 81.64% year-over-year to -$15.3 million; the TTM figure through Mar 2026 stood at $3.5 million (up 103.9% YoY), while the FY2025 annual figure was -$19.3 million, changed N/A from the prior year.
• Other Non Operating Income was -$15.3 million for Q1 2026 at Sarepta Therapeutics, up from -$157.9 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $387.3 million in Q1 2023 to a low of -$404.6 million in Q4 2023.
• Historically, Other Non Operating Income has averaged $138727.3 across 5 years, with a median of $6.5 million in 2024.
• Biggest YoY gain for Other Non Operating Income was 765.67% in 2025; the steepest drop was 1370.55% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $98.5 million in 2022, then tumbled by 510.8% to -$404.6 million in 2023, then jumped by 94.85% to -$20.8 million in 2024, then plunged by 658.4% to -$157.9 million in 2025, then soared by 90.34% to -$15.3 million in 2026.
• The last three Other Non Operating Income figures came in at -$15.3 million (Q1 2026), -$157.9 million (Q4 2025), and $138.6 million (Q3 2025), per Business Quant data.